Literature DB >> 6776826

Hyperosmotic NaCl and severe hemorrhagic shock.

I T Velasco, V Pontieri, M Rocha e Silva, O U Lopes.   

Abstract

Intravenous infusions of highly concentrated NaCl (2,400 mosmol/l; infused volume 4 ml/kg; equivalent to 10% of shed blood), given to lightly anesthetized dogs in severe hemorrhagic shock, rapidly restore blood pressure and acid base equilibrium toward normality. No appreciable plasma volume expansion occurs for at least 12 h, indicating that fluid shift into the vascular bed plays no essential role in this response. Initial effects wee sustained indefinitely; long term survival was 100%, compared to 0% for a similar group of controls treated with saline. Hemodynamic analysis of the effects of hyperosmotic NaCl showed that these infusions substantially increase mean and pulse arterial pressure, cardiac output and mesenteric flow, whereas heart rate was slightly diminished. These effects immediately follow infusions with no tendency to dissipate with time (6-h observation). We conclude that hyperosmotic NaCl infusions increase the dynamic efficiency of the circulatory system, enabling it to adequately handle oxygen supply and metabolite clearance, despite a critical reduction of blood volume.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776826     DOI: 10.1152/ajpheart.1980.239.5.H664

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  48 in total

Review 1.  [Small-volume resuscitation for hypovolemic shock. Concept, experimental and clinical results].

Authors:  U Kreimeier; F Christ; L Frey; O Habler; M Thiel; M Welte; B Zwissler; K Peter
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

Review 2.  Volume replacement and microhemodynamic changes in polytrauma.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2004-04-28       Impact factor: 3.445

Review 3.  Pulmonary contusion: an update on recent advances in clinical management.

Authors:  Stephen M Cohn; Joseph J Dubose
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

Review 4.  The effects of hypertonic saline in healthy and diseased animals.

Authors:  C Cambier; V Ratz; F Rollin; A Frans; T Clerbaux; P Gustin
Journal:  Vet Res Commun       Date:  1997-07       Impact factor: 2.459

5.  Hypertonic saline alters hydraulic conductivity and up-regulates mucosal/submucosal aquaporin 4 in resuscitation-induced intestinal edema.

Authors:  Ravi S Radhakrishnan; Shinil K Shah; Samuel H Lance; Hari R Radhakrishnan; Hasen Xue; Geetha L Radhakrishnan; Uma S Ramaswamy; Peter A Walker; Karen S Uray; Glen A Laine; Randolph H Stewart; Charles S Cox
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

6.  Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting.

Authors:  Xavier M Leverve; Cindy Boon; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Iqbal Mustafa
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

7.  The effects of hypertonic saline solution on coronary blood flow in anaesthetized pigs.

Authors:  G Vacca; B Papillo; A Battaglia; E Grossini; D A Mary; G Pelosi
Journal:  J Physiol       Date:  1996-03-15       Impact factor: 5.182

8.  Hypertonic saline up-regulates A3 adenosine receptor expression of activated neutrophils and increases acute lung injury after sepsis.

Authors:  Yoshiaki Inoue; Yu Chen; Reinhard Pauzenberger; Mark I Hirsh; Wolfgang G Junger
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

9.  Blood loss and transcapillary refill in uncontrolled treated hemorrhage in dogs.

Authors:  Elias Aissar Sallum; Sueli Sinozaki; Ana Maria Calil; Raul Coimbra; Maurício Rocha E Silva; Luis Francisco Poli de Figueiredo; Dario Birolini
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

10.  Cited Brazilian papers in general surgery between 1970 and 2009.

Authors:  Flavio L Heldwein; Antonio A Hartmann; Antonio N Kalil; Bruno V D Neves; Giorigo S B Ratti; Moises C Beber; Rafael M Souza; Armando J d'Acampora
Journal:  Clinics (Sao Paulo)       Date:  2010-05       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.